1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders Article

Benek, Ondrej, Hroch, Lukas, Aitken, Laura et al. (2018). 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders . 33(1), 665-670. 10.1080/14756366.2018.1445736

Open Access International Collaboration

cited authors

  • Benek, Ondrej; Hroch, Lukas; Aitken, Laura; Gunn-Moore, Frank; Vinklarova, Lucie; Kuca, Kamil; Perez, Daniel I; Perez, Concepcion; Martinez, Ana; Fisar, Zdenek; Musilek, Kamil

sustainable development goals

authors

publication date

  • March 14, 2018

keywords

  • Alzheimer's disease
  • BLOOD-BRAIN-BARRIER
  • Biochemistry & Molecular Biology
  • Chemistry, Medicinal
  • DISEASES
  • Life Sciences & Biomedicine
  • Pharmacology & Pharmacy
  • Science & Technology
  • amyloid-beta binding alcohol dehydrogenase (ABAD)
  • benzothiazole
  • casein kinase 1 (CK1)
  • neurodegeneration

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 665

end page

  • 670

volume

  • 33

issue

  • 1